MYRIAD GENETICS, INC. Deferred Tax Assets, Operating Loss Carryforwards
MYRIAD GENETICS, INC. (MYGN) had Deferred Tax Assets, Operating Loss Carryforwards of $82.50 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-24
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $82.50M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $62.70M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $77.10M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $66.60M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $82.50M 10-K · filed 2026-02-24 | |
| 2024-12-31 | $62.70M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $77.10M 10-K · filed 2025-02-28 | |
| 2022-12-31 | $66.60M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $67.20M 10-K · filed 2023-03-01 | |
| 2020-12-31 | $72.20M 10-K · filed 2022-02-25 | |
| 2020-06-30 | $73.10M 10-KT · filed 2021-03-16 | |
| 2019-06-30 | $85.70M 10-KT · filed 2021-03-16 | |
| 2018-06-30 | $44.60M 10-K · filed 2019-08-13 | |
| 2017-06-30 | $75.50M 10-K · filed 2018-08-24 | |
| 2016-06-30 | $54.40M 10-K · filed 2017-08-09 | |
| 2015-06-30 | $61.10M 10-K · filed 2016-08-10 | |
| 2014-06-30 | $77.00M 10-K · filed 2015-08-12 | $76.99M 10-K · filed 2014-08-13 |
| 2013-06-30 | $8.34M 10-K · filed 2014-08-13 | |
| 2012-06-30 | $7.78M 10-K · filed 2013-08-14 | |
| 2011-06-30 | $6.53M 10-K · filed 2012-08-15 | |
| 2010-06-30 | $37.93M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |